Background: making informed decisions about cancer care provision for older cancer patients can be challenging and complex. Evidence suggests cancer care varies by age, however the relationship between age and care experiences from diagnosis to death for cancer patients within the UK has not previously been examined in detail. Patients and methods: retrospective cohort linking cancer registry and secondary care data for 13,499 adult cancer patients who died between January 2005 and December 2011. Cancer therapies (chemotherapy, radiotherapy, surgery), hospital palliative care referrals, hospital admissions and place of death were compared between age groups using multivariable regression models. Trends in cancer care over time, overall and within age groups were also assessed. Results: compared with adult patients under 60 years, patients aged 80 years and over were less likely to receive chemotherapy, radiotherapy, a hospital palliative care referral; or be admitted to hospital but were more likely to die in a care home. Overall, the percentage of patients receiving chemotherapy, surgery, hospital palliative care referrals and hospital admissions have increased while deaths in hospital have decreased. Deaths at home have increased for patients aged 80 years and over. Conclusion: older patients are less likely to receive cancer therapies or hospital palliative care before death. Further research is needed to identify the extent to which these results reflect unmet need.
Introduction
Cancer is a disease which is closely allied with older age, with most registrations and cancer deaths occurring in those aged 65 years and over [1, 2] . Projections from the United Kingdom (UK) suggest that cancer registrations and deaths in older age groups are likely to increase as the population ages [3] .
Living and dying well with cancer is a key priority for the UK National Health Service (NHS) [4, 5] . Making informed decisions along the cancer continuum about the most appropriate course of action can be challenging and complex [6] . This can be particularly so when caring for older patients due to existing comorbidities. Assessing the benefit of treatments for older patients can also be particularly difficult as many clinical trials explicitly exclude older adults [7] .
Existing evidence suggests that older cancer patients are less likely to receive cancer therapies [8] [9] [10] [11] or palliative care support [12, 13] and require less hospital activity [11, 14] compared with younger patients; however, this evidence is derived from outdated studies [8, 10, 11] or studies based on small samples [8] , limited to specific cancer types [10, 11] , addressing specific aspects of cancer management [8, 10, [12] [13] [14] or based only on clinical opinion [9] . In addition, no studies have explored the age-related differences for cancer patients who subsequently die.
These studies highlight the need for a large study assessing variations in cancer care between age groups for a broad range of cancer care outcomes, from diagnosis to death. We aimed to describe principal cancer treatments and palliative care received by a large cohort of patients who died from cancer over a 7-year period to provide a more detailed and comprehensive analysis.
Methods

Study design
A population-based retrospective cohort study.
Patients and data
Patients were included if they were aged 18 years or over at date of death; resided within Leeds, a large city within Northern England, died between January 2005 and December 2011, and cancer was recorded on their death certificate. Data were obtained from the Northern and Yorkshire Cancer Registry (NYCR) and the Patient Pathway Manager (PPM), a clinical information system used by Leeds Teaching Hospitals Trust (LTHT), which includes seven NHS hospitals and provides specialist cancer services for up to 5.4 million people.
An open pseudonymiser system was used to link datasets, using an encrypted code based on NHS numbers.
Variables
Outcomes
Patients were identified as having received or not received, at any point from first cancer diagnosis, the following care: chemotherapy, radiotherapy, surgery, hospital palliative care referral and hospital admission (emergency or any). Information on chemotherapy and radiotherapy received, hospital palliative care and hospital admissions were extracted from the PPM. We obtained information on whether the patient had received surgery from the NYCR information system.
Place of death was provided by NYCR and was categorised as 'Own home', 'Hospice', 'Hospital', 'Care home' or 'Other/Unknown'.
Patient characteristics
Age at death was stratified into 18-59, 60-69, 70-79 and 80 years and over. Other patient characteristics included were gender, Indices of Multiple Deprivation (IMD) quintile (measure of socio-economic deprivation), first cancer diagnosis (categorised into broad groups) and duration of illness (calculated by subtracting date of death from the date of first cancer diagnosis).
Indicators of comorbidity were available only from the death certificate. As evidence suggests comorbidities may be under-reported on death certificates but underlying cause of death (UCOD) is generally reported accurately [15] , UCOD reported as cancer was included to identify patients in whom cancer contributed to the death but was not the underlying cause. Circulatory disease (ICD10 I00-I99) included on the death certificate was also included as a proxy measure as this disease group represents the most common causes of death, alongside cancer.
Data analysis
Frequencies and percentages were used to summarise categorical patient characteristics and cancer care by age groups. Median and interquartile range (IQR) were used to summarise duration of illness. Patient characteristics and cancer care were compared by age group using the Pearson's chi-squared test (χ 2 ), for categorical outcome variables, and the KruskalWallis test, for numerical outcome variables.
All cancer care outcomes except place of death were assessed using multivariable logistic regression analyses to compare odds ratios (ORs). The place of death was assessed using multivariable multinomial logistic regression, comparing the relative risk ratios (ORs) of dying at home, in a hospice and in a care home, relative to dying in hospital. Age group was included in the models as the independent variable, with age group 18-59 years used as the reference group. Gender, year of death, IMD quintile, first cancer diagnosis, cancer UCOD, death certificate included circulatory disease and duration of illness were included in the models as extraneous factors. Trends over time in cancer care outcomes for each of the age groups were assessed using the χ 2 test for trend.
All data manipulation and analysis were performed using IBM SPSS version 23.
Results
Comparisons of patient characteristics and cancer care by age at death are presented in Table 1 .
Patient characteristics
The study included 13,499 deceased adult cancer patients, the majority (55.9%) were aged 70 years or over.
Overall, 53.8% of patients were male. The most common cancer sites were cancers of the trachea, bronchus and Gender (P < 0.001), deprivation IMD quintile (P < 0.001), cancer site (P < 0.001), UCOD reported as cancer (P < 0.001), death certificate included circulatory disease (P < 0.001) and duration of illness (P < 0.001) were all significantly associated with age group.
Cancer care
Most (93.5%) patients received some cancer treatment, with approximately half received chemotherapy (49.0%), sixty percent (60.7%) received radiotherapy, and over one-third received surgery (34.5%). The likelihood of receiving any treatment (P < 0.001), chemotherapy (P < 0.001), radiotherapy (P < 0.001) or surgery (P = 0.009) were all significantly associated with age group. The likelihood of receiving chemotherapy, radiotherapy or surgery were all highest in the youngest age group (18-59 years), at 68.7, 64.5 and 37.3% respectively, and lowest in the oldest age group (80 plus years), at 27.1, 57.6, and 33.6% respectively.
The percentage of patients receiving a hospital palliative care referral (28.6%) and the percentage of patients experiencing at least one hospital admission, overall (38.6%) and as an emergency (29.8%), were also significantly associated with age group (all P < 0.001). In all cases, the highest percentages were in the 18-59 years age groups (hospital palliative care: 36.1%, all admissions: 42.5%; emergency admissions: 33.3%) and the lowest in the 80 plus age group (hospital palliative care: 23.4%, all admissions: 35.7%; emergency admissions: 27.4%).
The place of death was significantly associated with age group (P < 0.001). The percentage of hospice deaths were highest in the 18-59 years age group, at 36.0% reducing to 25.5% in the 80 plus age group. The percentage of patients dying in a care home was highest in the 80 plus age group, at 14.7%. Figure 1 shows the ORs by age group, alongside 95% confidence intervals (CIs), for each cancer care outcome from the multivariable logistic and multinomial logistic regression models after controlling for the extraneous variables. Please see Supplementary data, Appendix 1A-1C, are available in Age and Ageing online on the journal website (http://www. ageing.oxfordjournals.org/) for full results.
Multivariable analysis
The odds of receiving chemotherapy (P < 0.001), receiving radiotherapy (P < 0.001), receiving a hospital palliative care referral (P < 0.001) and being admitted to hospital (all admissions: P < 0.001, emergency admissions: P < 0.001) all differed significantly between age groups, with significantly lower odds in patients in the older age groups compared with patients aged 18-59 years.
The likelihood of receiving surgery also differed significantly by age group (P < 0.001), with patients aged 60-69 years (OR: 1.15, 95% CI: 1.01-1.30) and 70-79 years (OR: 1.18, 95% CI: 1.05-1.33) having significantly higher odds of receiving surgery compared to patients aged 18-59 years.
Significant differences were found overall between age groups for the odds of dying in a hospice (P = 0.016) and dying in a care home (P < 0.001), compared with dying in hospital, however there was no significant difference by age group in the likelihood of dying at home compared to dying in hospital (P = 0.145). The odds of dying in a care home increased with age. 
Trends over time
Trends in cancer care by age and year of death are presented in Figure 2 .
A significant increasing trend in the percentage of patients receiving chemotherapy was identified overall (P < 0.001), and for all age groups except patients aged 60-69 years, with an overall increase from 45.6% to 52.4%. The percentage of patients who received surgery showed an increasing trend overall (P < 0.001) from 31.0% to 38.7%, and for all except the youngest age group (18-59 years). Hospital palliative care also showed an increasing trend overall, from 25.6% to 28.0% (P = 0.006); however, within age groups, this trend was only significant for patients aged 60-69 years (P = 0.018). There was no significant trend in the percentage of patients receiving radiotherapy before death (P = 0.651).
Admissions to hospital and emergency only admissions to hospital increased (both P < 0.001) from 36.3% to 47.4% and from 26.1% to 38.5%, respectively. Significant increasing trends in hospital admissions were observed for all age groups.
Significant trends were found for all ages combined in the percentage of patients dying in hospital (P < 0.001), at home (P = 0.007) and in a care home (P < 0.001). Between 2005 and 2011, the percentage of deaths in hospital reduced from 36.0% to 31.3%, while the percentage of deaths at home and in a care home increased from 28.0% to 31.0% and from 5.4% to 7.9%, respectively, for all age groups.
Within age groups, no significant trends in place of death were identified for patients aged 18-59 and 70-79 years. Significant reductions were identified in the percentage of deaths in hospital for patients aged 60-69 years (P = 0.003) and 80 years and over (P = 0.01). Patients aged 60-69 years also experienced a significant increasing trend in the percentage of deaths in a care home (P < 0.001). Patients aged 80 years and over experienced a significant increasing trend in the percentage of home deaths (P = 0.005).
Discussion
To our knowledge, this is the largest analysis of hospitalbased cancer and palliative care provided to patients from diagnosis to death. Our results show even after controlling for comorbidities there were significant differences in cancer care by age group. We found older patients with cancer were less likely to receive chemotherapy or radiotherapy, be referred to hospital palliative care services or be admitted to hospital, as an emergency or planned admission. In terms of place of death, older patients were more likely to die in a care home, but differences in the percentages of deaths at home or in a hospice between age groups were not significant once other patient characteristics were taken into consideration.
The percentages of patients receiving chemotherapy, surgery, a hospital palliative care referral, admission to hospital and dying at home or in a care home all show an increasing trend overall, while the percentage of patients dying in a hospice has remained fairly stable over the period for all age groups. The percentage of hospital deaths showed a decreasing trend overall and for patients aged 60-69 years and 80 years and over in particular.
The results for chemotherapy and radiotherapy support previous research from small or cancer site-specific studies which showed that older patients with cancer were less likely to receive cancer therapies [8-11, 16, 17] . While this may be explained by increased risk factors associated with age, differences in need between age groups, variation in disease status or differences in existing support [18] [19] [20] . Evidence suggests that to a greater or lesser extent, chronological age may be influencing treatment or care decisions [9, 21, 22] .
The lower percentage of hospital-based palliative care for older adults is likely to reflect the lower proportion of older adults admitted to hospital compared with younger patients. The lower levels of older adults receiving an emergency hospital admission is encouraging as this outcome is considered an indicator for poor cancer care [23] . The reasons for this difference between ages are not known but may reflect differences in the care needs and existing support services available [14, 17] .
Most people who express a preference would prefer to die at home rather than in hospital and a home death is often used as an indicator for quality end-of-life care [24] . Our study found that though a higher percentage of younger patients die at home or in a hospice compared to older patients, after taking other factors, including comorbidities, into account, there were no significant differences between age groups when comparing dying at home or hospice compared to dying in hospital. The main differences in place of death between ages were in comparisons between dying in a care home compared with dying in hospital, with a reduced likelihood of dying in a hospital for older patients. This substantiates the evidence that care homes are frequently the main provider of end-of-life care [14] and highlights the need for palliative care skills to be embedded within these settings.
Several limitations should be noted when interpreting these findings. First, the data come from a single UK city. While the population is broadly representative of the UK, in terms of patient demographics and cancer prevalence, the cancer care was delivered by one of the UK's largest cancer treatment centres and consequently may reflect best UK cancer care. Second, the availability and completeness of data extracted from the clinical systems meant that some items, including illness stage, comorbidities, and treatment start date, could not be included. Additionally though routine clinical data areconsidered fairly robust, we cannot exclude the possibility of inherent coding errors [25] . Finally, our eligibility criteria were limited to only cancer patients who subsequently died, with cancer record on the death certificate. This enabled us to address our aim to assess cancer care from diagnosis to death, the results cannot be used to represent all cancer patients.
Conclusion
Older age is associated with less cancer treatment [16] . Further research is needed to identify the extent to which these results reflect unmet need.
Key points
• Cancer care provision differed between age groups.
• Older patients were less likely to have received chemotherapy, radiotherapy, hospital palliative care or hospital admission.
• Older patients were more likely to die in a care home.
• Deaths at home increased while deaths in hospital decreased between 2005 and 2011 for older cancer patients.
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